A multicenter, prospective randomized trial comparing two types of self-expanding stents in the palliation of malignant dysphagia: SEMS (Ultraflex stent) versus SEPS (Polyflex ste…
A Eickhoff, D Hartmann, R Kiesslich, S Turi, M Lerch, PR Galle, JF Riemann · Zeitschrift für Gastroenterologie · 2007 · Heft 09
Bibliografische Angaben
Zusammenfassung
Aims: High-grade dysphagia is the predominant late symptom of local advanced esophagogastric cancer. Placement of self-expandable metal stents (SEMS) is an established method of treatment for inoperable esophagogastric cancers. The major disadvantage of SEMS is its high upfront costs. A new self-expandable plastic stent (SEPS) has been developed recently. Aim and methods: To evaluate efficacy and outcome of a special type of SEMS (Ultraflex stent) versus the new designed SEPS (Polyflex stent) in malignant dysphagia. Multicenter, prospective randomized trial of 47 patients (pts.) with malignant dysphagia. 23 pts.…